Inventor · disambiguated record
Taekyu Lee
Also filed as: LEE TAEKYU · ROBICHAUD ALBERT J
33 granted patents·5 pending applications·1,794 citations·filing 1998–2022
98Inventor score
Files withUNIV VANDERBILT15BRISTOL MYERS SQUIBB CO10BRISTOL MYERS SQUIBB PHARMA CO10SCRIPPS RESEARCH INST1
Top patents by PatentIndex Score
38 records- 0198US7238690B2Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jul 3, 2007·127 cites·4 claims
- 0298US7183282B2Substituted heterocycle fused γ-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Feb 27, 2007·145 cites·4 claims
- 0398US6849619B2Substituted pyridoindoles as serotonin agonists and antagonistsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 1, 2005·119 cites·26 claims
- 0498US6552017B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 22, 2003·208 cites·21 claims
- 0597USRE39680ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·142 cites·21 claims
- 0697USRE39679ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·129 cites·33 claims
- 0797US7081455B2Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 25, 2006·115 cites·17 claims
- 0897US7071186B2Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jul 4, 2006·121 cites·15 claims
- 0997US6713471B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 30, 2004·172 cites·33 claims
- 1097US6548493B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 15, 2003·179 cites·23 claims
- 1196US7592454B2Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonistsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 22, 2009·62 cites·7 claims
- 1296US6699852B2Substituted pyridoindoles as serotonin agonists and antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Mar 2, 2004·130 cites·20 claims
- 1394US7109339B2Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 19, 2006·88 cites·5 claims
- 1493US7858639B2Bicyclic heterocycles as cannabinoid-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Dec 28, 2010·30 cites·15 claims
- 1586US7632837B2Bicyclic heterocycles as cannabinoid-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 15, 2009·5 cites·15 claims
- 1684US10844044B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2019·Granted Nov 24, 2020·4 cites·20 claims
- 1780US10533010B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2015·Granted Jan 14, 2020·3 cites·15 claims
- 1878US10807959B2WDR5-MLL1 inhibitors and modulatorsUNIV VANDERBILT·Filed 2019·Granted Oct 20, 2020·2 cites·18 claims
- 1975US12144816B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2022·Granted Nov 19, 2024·0 cites·16 claims
- 2074US11596639B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2017·Granted Mar 7, 2023·1 cites·20 claims
- 2173US12195472B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2021·Granted Jan 14, 2025·0 cites·17 claims
- 2272US11999716B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2019·Granted Jun 4, 2024·1 cites·12 claims
- 2371US7572808B2Triazolopyridine cannabinoid receptor 1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Aug 11, 2009·1 cites·13 claims
- 2470US6777406B2Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Aug 17, 2004·5 cites·18 claims
- 2567US11208415B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2019·Granted Dec 28, 2021·0 cites·17 claims
- 2667US6638934B2Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Oct 28, 2003·3 cites·22 claims
- 2765US10005728B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2014·Granted Jun 26, 2018·0 cites·25 claims
- 2861US10954193B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2018·Granted Mar 23, 2021·0 cites·19 claims
- 2956US10844032B2Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2018·Granted Nov 24, 2020·0 cites·20 claims
- 3056US10093640B2Substituted benzofuran, benzothiophene and indole MCL-1 inhibitorsUNIV VANDERBILT·Filed 2013·Granted Oct 9, 2018·0 cites·21 claims
- 3155US2004034015A1Substituted heterocycle fused gamma-carbolinesFiled 2003·Application pending·0 cites
- 3254US2004127482A1Substituted heterocycle fused gamma-carbolinesFiled 2003·Application pending·0 cites
- 3351US7795436B2Substituted tricyclic heterocycles as serotonin receptor agonists and antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 14, 2010·0 cites·7 claims
- 3451US2024262822A1Wdr5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 3545US2007027178A1Substituted tetrahydro-1H-pyrido[4,3-b]indoles as serotonin receptors agonists and antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 3645US2023026466A1Wdr5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2020·Application pending·0 cites
- 3739US6803466B1HIV/FIV protease inhibitors having a small P3 residueSCRIPPS RESEARCH INST·Filed 1998·Granted Oct 12, 2004·2 cites·13 claims
- 3836US9949965B2Tricyclic indole Mcl-1 inhibitors and uses thereofUNIV VANDERBILT·Filed 2015·Granted Apr 24, 2018·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Taekyu Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →